WHO ICTRP trial

Effect of the type of oil on treatment of non-alcoholic fatty liver disease

IRCT20170206032417N5 · Iranian Registry of Clinical Trials (IRCT) · Recruiting

Key facts

Trial ID IRCT20170206032417N5
Public title Effect of the type of oil on treatment of non-alcoholic fatty liver disease
Scientific title Evaluating the effects of replacing ghee with rapeseed oil on liver steatosis and enzymes, lipid profile, insulin resistance, and anthropometric measurements in patients with non-alcoholic fatty liver disease
Primary sponsor Oroumia University of Medical Sciences
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Recruiting
Study type interventional
Countries Iran (Islamic Republic of)
Conditions Non alcoholic fatty liver disease. Fatty (change of) liver, not elsewhere classified;K76.0
Interventions Intervention 1: Intervention group: The intervention group, in addition to the usual treatment, will be recommended to change their fat intake to rapeseed oil. Intervention 2: Control group: At first, people with daily consumption of 3 -8…
Registration date Jan 18, 2022
Target size 110
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations